Vladimir Bykov

Vladimir Bykov

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
JBJ. G. Birulina
J. G. Birulina
VIVladimir Ivanov
Vladimir Ivanov
EBEvgeny Buyko
Evgeny Buyko
VBVladimir Bykov
Vladimir Bykov
LSL V. Smagliy
L V. Smagliy
SGSvetlana Gusakova
Svetlana Gusakova
Экспериментальная модель метаболического синдрома у крыс на основе высокожировой и высокоуглеводной диеты

1 April 2022 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VBVladimir Bykov
Vladimir Bykov
VSV. I. Smol’yakova
V. I. Smol’yakova
GCG. A. Chernysheva
G. A. Chernysheva
OAO. I. Aliev
O. I. Aliev
AAA. M. Anishchenko
A. M. Anishchenko
VKV. A. Khazanov
V. A. Khazanov

25 April 2020 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VBVladimir Bykov
Vladimir Bykov
KLK. A. Leonov
K. A. Leonov
VSV. Yu. Serebrov
V. Yu. Serebrov
GCG. A. Chernysheva
G. A. Chernysheva
VSV. I. Smol’yakova
V. I. Smol’yakova
VUV. V. Udut
V. V. Udut

4 January 2022 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
Vladimir V. ZarubaevVladimir V. Zarubaev
Vladimir V. Zarubaev
AGAngelica V. Garshinina
Angelica V. Garshinina
AVAleksandrina Volobueva
Aleksandrina Volobueva
ASAlexander Valentinovich Slita
Alexander Valentinovich Slita
Olga I. YarovayaOlga I. Yarovaya
Olga I. Yarovaya
NSNariman F. Salakhutdinov
Nariman F. Salakhutdinov

30 August 2022 in Drug development & registration
Verified
Journal Article
Open access
PDF file
VBVladimir Bykov
Vladimir Bykov
ABA. V. Bykova
A. V. Bykova
VSV. I. Smolyakova
V. I. Smolyakova
GCG. A. Chernysheva
G. A. Chernysheva
OAO. I. Alyev
O. I. Alyev
АВА. И. Венгеровский
А. И. Венгеровский
Антитромботическая активность производного индолинона – стимулятора растворимой гуанилатциклазы

12 October 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
JBJ. G. Birulina
J. G. Birulina
VIVladimir Ivanov
Vladimir Ivanov
EBEvgeny Buyko
Evgeny Buyko
VBVladimir Bykov
Vladimir Bykov
ADAnna Dzyuman
Anna Dzyuman
SGSvetlana Gusakova
Svetlana Gusakova
Aim. To identify early morphological changes in the heart and aorta of rats with experimental metabolic syndrome induced by a high-fat and high-carbohydrate diet (HFHCD).Materials and methods. The study was carried out on male Wistar rats. The animals were divided into two groups: a control group (n = 10) and an experimental group (n = 10). The rats from the control group were fed with a standard laboratory diet. The rats from the experimental group received HFHCD for 12 weeks. Body weight, blood pressure (BP), and individual parameters of carbohydrate and lipid metabolism were assessed in the rats. A histologic examination of the heart and aorta in the animals was performed.Results. Feeding rats with HFHCD led to an increase in body weight, elevation of BP, obesity, hyperglycemia, and triglyceridemia. The histologic examination of the heart in the rats of the experimental group showed signs of vascular disease, lipomatosis, and focal myocardial degeneration. Lipid accumulation in the cells of the media, hyperplasia of adipocytes in the adventitia, and depletion and fragmentation of the elastic lamina were revealed in the aortic wall of the rats receiving HFHCD.Conclusion. The study indicated that HFHCD is an effective way to model metabolic syndrome. Structural disorders in the heart and aorta may be the mainstay for the development of cardiomyopathy and arterial hypertension in diet-induced metabolic syndrome.